Tapani Liukkonen

1.0k total citations
25 papers, 763 citations indexed

About

Tapani Liukkonen is a scholar working on Surgery, Urology and Molecular Biology. According to data from OpenAlex, Tapani Liukkonen has authored 25 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 5 papers in Urology and 4 papers in Molecular Biology. Recurrent topics in Tapani Liukkonen's work include Bladder and Urothelial Cancer Treatments (20 papers), Urinary and Genital Oncology Studies (16 papers) and Esophageal Cancer Research and Treatment (4 papers). Tapani Liukkonen is often cited by papers focused on Bladder and Urothelial Cancer Treatments (20 papers), Urinary and Genital Oncology Studies (16 papers) and Esophageal Cancer Research and Treatment (4 papers). Tapani Liukkonen collaborates with scholars based in Finland, Qatar and Portugal. Tapani Liukkonen's co-authors include Eero Kaasinen, Erkki Rintala, Pertti Rajala, Mika Raitanen, P. Lipponen, Jouko Viitanen, Per M. Hellström, H. Korhonen, M Helle and Harri Juusela and has published in prestigious journals such as The Journal of Urology, European Urology and Urology.

In The Last Decade

Tapani Liukkonen

25 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tapani Liukkonen Finland 15 599 177 133 120 112 25 763
T.S. O'Brien United Kingdom 10 225 0.4× 21 0.1× 87 0.7× 182 1.5× 144 1.3× 22 555
Edwards United Kingdom 9 142 0.2× 55 0.3× 40 0.3× 46 0.4× 8 0.1× 34 413
Stephanie Stapleton United States 8 114 0.2× 15 0.1× 49 0.4× 142 1.2× 74 0.7× 20 409
Thomas Akkad Austria 11 303 0.5× 93 0.5× 57 0.4× 70 0.6× 2 0.0× 26 462
Athanasios Pappas Greece 10 62 0.1× 74 0.4× 31 0.2× 40 0.3× 5 0.0× 23 304
Cristián García Chile 12 153 0.3× 17 0.1× 49 0.4× 39 0.3× 5 0.0× 31 440
Franco Palmisano Italy 12 121 0.2× 118 0.7× 49 0.4× 28 0.2× 4 0.0× 52 465
Kevin Mulcahy United Kingdom 11 186 0.3× 21 0.1× 42 0.3× 121 1.0× 3 0.0× 17 448
D. Baron France 12 98 0.2× 25 0.1× 27 0.2× 29 0.2× 37 0.3× 38 522
J.P. Eschard France 10 99 0.2× 10 0.1× 25 0.2× 40 0.3× 21 0.2× 18 396

Countries citing papers authored by Tapani Liukkonen

Since Specialization
Citations

This map shows the geographic impact of Tapani Liukkonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tapani Liukkonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tapani Liukkonen more than expected).

Fields of papers citing papers by Tapani Liukkonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tapani Liukkonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tapani Liukkonen. The network helps show where Tapani Liukkonen may publish in the future.

Co-authorship network of co-authors of Tapani Liukkonen

This figure shows the co-authorship network connecting the top 25 collaborators of Tapani Liukkonen. A scholar is included among the top collaborators of Tapani Liukkonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tapani Liukkonen. Tapani Liukkonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ettala, Otto, Ileana Montoya Perez, Riikka Järvinen, et al.. (2022). Awareness of Smoking as a Risk Factor in Bladder Cancer: Results from the Prospective FinnBladder 9 Trial. European Urology Focus. 8(5). 1246–1252. 6 indexed citations
2.
Ettala, Otto, Ileana Montoya Perez, Riikka Järvinen, et al.. (2019). Symptoms and diagnostic delays in bladder cancer with high risk of recurrence: results from a prospective FinnBladder 9 trial. World Journal of Urology. 38(4). 1001–1007. 7 indexed citations
3.
Räisänen, Jouni, Hannes Enlund, Tapani Liukkonen, et al.. (2018). The Finnish Interprofessional Medication Assessment (FIMA): baseline findings from home care setting. Aging Clinical and Experimental Research. 31(10). 1471–1479. 9 indexed citations
4.
Marttila, Timo, Riikka Järvinen, Tapani Liukkonen, et al.. (2016). Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-α2a in Reducing Recurrence of Non–Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study. European Urology. 70(2). 341–347. 25 indexed citations
5.
6.
Sallinen, Ville, Henrikki Santti, Tapani Liukkonen, et al.. (2013). Safety and long-term results of endoscopic transanal resection in treating rectal adenomas: 15 years’ experience. Surgical Endoscopy. 27(9). 3431–3436. 2 indexed citations
7.
8.
Kaasinen, Eero, Erkki Rintala, Per M. Hellström, et al.. (2002). Factors Explaining Recurrence in Patients Undergoing Chemoimmunotherapy Regimens for Frequently Recurring Superficial Bladder Carcinoma. European Urology. 42(2). 167–174. 107 indexed citations
9.
10.
Raitanen, Mika, Risto Aine, Eevi Kaasinen, et al.. (2002). Suspicious Urine Cytology (Class III) in Patients with Bladder Cancer: Should it be Considered as Negative or Positive?. Scandinavian Journal of Urology and Nephrology. 36(3). 213–217. 17 indexed citations
11.
Raitanen, Mika, Eero Kaasinen, O Lukkarinen, et al.. (2001). Analysis of false-positive BTA stat test results in patients followed up for bladder cancer. Urology. 57(4). 680–684. 33 indexed citations
12.
Liukkonen, Tapani, P. Lipponen, Mika Raitanen, et al.. (2000). Evaluation of p21 WAF1/CIP1 and cyclin D 1 expression in the progression of superficial bladder cancer. Urological Research. 28(5). 285–292. 39 indexed citations
13.
14.
Liukkonen, Tapani, Pertti Rajala, Mika Raitanen, et al.. (1999). Prognostic Value of MIB-1 Score, p53, EGFr, Mitotic Index and Papillary Status in Primary Superficial (Stage pTa/T1) Bladder Cancer: A Prospective Comparative Study. European Urology. 36(5). 393–400. 80 indexed citations
15.
Alfthan, O, K. Jauhiainen, Eero Kaasinen, & Tapani Liukkonen. (1997). Current concepts in the role of intravesical instillations in the therapy and prophylaxis of superficial transitional-cell cancer of the bladder. World Journal of Urology. 15(2). 89–95. 3 indexed citations
16.
Liukkonen, Tapani, et al.. (1997). Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Urological Research. 25(1). 1–8. 27 indexed citations
17.
Liukkonen, Tapani, P. Lipponen, M Helle, et al.. (1996). Expression of MIB-1, mitotic index and S-phase fraction as indicators of cell proliferation in suerficial bladder cancer. Urological Research. 24(1). 61–66. 7 indexed citations
18.
Lüthje, Peter, Ilona Nurmi, Matti Kataja, et al.. (1996). Epidemiology and traumatology of injuries in elite soccer: a prospective study in Finland. Scandinavian Journal of Medicine and Science in Sports. 6(3). 180–185. 125 indexed citations
19.
Lipponen, P. & Tapani Liukkonen. (1995). Reduced expression of retinoblastoma (Rb) gene protein is related to cell proliferation and prognosis in transitional-cell bladder cancer. Journal of Cancer Research and Clinical Oncology. 121(1). 44–50. 34 indexed citations
20.
Karppanen, Heikki, Tapani Liukkonen, Ilari Paakkari, & Pirkko Paakkari. (1977). CENTRAL HYPOTENSIVE EFFECTS OF ANGIOTENSIN II IN THE RAT. Acta Medica Scandinavica. 201(S602). 103–105. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T.S. O'Brien Breakdown of academic impact, for papers by Edwards Breakdown of academic impact, for papers by Stephanie Stapleton Breakdown of academic impact, for papers by Thomas Akkad Breakdown of academic impact, for papers by Athanasios Pappas Breakdown of academic impact, for papers by Cristián García Breakdown of academic impact, for papers by Franco Palmisano Breakdown of academic impact, for papers by Kevin Mulcahy Breakdown of academic impact, for papers by D. Baron Breakdown of academic impact, for papers by J.P. Eschard
Rankless by CCL
2026